Friday, October 30, 2009
Cipla, the third largest pharma company in India has achieved impressive growth in profitability during the second quarter ended September 2009. Its net profit moved up by 82.1 per cent to Rs 275.74 crore from Rs 151.43 crore in the similar period of last year. Its net sales, however, improved marginally by 5 per cent to Rs 1,384 crore as against Rs 1,318 crore. Though the domestic sales improved by 6.8 per cent to Rs 631 crore, its exports declined by 3.4 per cent to Rs 581.91 crore from Rs 602.34 crore. The sales of API & others increased smartly by 37.5 per cent to Rs 170.56 crore from Rs 124.02 crore.
For the first half ended September 2009, Cipla’s net sales increased by 8.7 per cent to Rs 2,723 crore from Rs 2,505 crore in the same period of last year. Its net profit went up by 77.5 per cent to 517.45 crore from Rs 291.47 crore. Exports increased by 10 per cent to Rs 1,129 crore in the first half of 2009-10 from Rs 1,027 crore. Similarly, its domestic sales moved up by 9.1 per cent to Rs 1,283 crore from Rs 1,177 crore.
Cipla, the third largest pharma company in India has achieved impressive growth in profitability during the second quarter ended September 2009. Its net profit moved up by 82.1 per cent to Rs 275.74 crore from Rs 151.43 crore in the similar period of last year. Its net sales, however, improved marginally by 5 per cent to Rs 1,384 crore as against Rs 1,318 crore. Though the domestic sales improved by 6.8 per cent to Rs 631 crore, its exports declined by 3.4 per cent to Rs 581.91 crore from Rs 602.34 crore. The sales of API & others increased smartly by 37.5 per cent to Rs 170.56 crore from Rs 124.02 crore.
For the first half ended September 2009, Cipla’s net sales increased by 8.7 per cent to Rs 2,723 crore from Rs 2,505 crore in the same period of last year. Its net profit went up by 77.5 per cent to 517.45 crore from Rs 291.47 crore. Exports increased by 10 per cent to Rs 1,129 crore in the first half of 2009-10 from Rs 1,027 crore. Similarly, its domestic sales moved up by 9.1 per cent to Rs 1,283 crore from Rs 1,177 crore.
No comments:
Post a Comment